Jakafi - Blood Cancer - Jun Display Banners HCP Wallboard Extension - 26352 - Physician's Weekly


Advertisement

Jakafi – Blood Cancer – Jun Display Banners HCP Wallboard Extension – 26352

Drug Combo Ups Event-Free Survival in IDH1-Mutated AML

Compared with placebo and azacitidine, the combination of ivosidenib plus azacitidine prolongs event-free survival for patients with newly diagnosed IDH1-mutated acute myeloid leukemia (AML) who are ineligible for induction...

Post-Kidney Transplant Survival Minimally Affected by MM

Patients with renal failure due to multiple myeloma (MM) who underwent kidney transplant (KT) had equivalent graft and age-matched overall survival (OS) compared with the general KT population, according to a study published in...

End-of-Life Planning: Your Patients Are Ready & They Need it

Many of us were drawn to medicine by a deeply compelling purpose: to save and improve lives. However, as physicians, our duty extends beyond disease prevention, diagnosis, and treatment—we are also charged with helping our...

Loading

Advertisement

For latest news and updates
Email-id is invalid